– a generally known phenomenon? This is probably because it is being referenced more and more in policy (and funding related) documents and this is because multimorbidity is identified as a cause of increased health care costs.
A few decades ago, chronic diseases began to assume importance as they became relatively more common when compared to acute illnesses and as infectious diseases have become more treatable. Co-morbidities then began to be mentioned in specialist clinics where it was noted that, for instance, patients with COPD might also have cardiac or peripheral vascular disease – and that these co-morbidities and their treatments might impact on the disease under care.
This was a rather specialist view. In the Geriatric
In
The American Geriatric Society has produced a handy Pocketcard summary of their guidelines.
In the UK, Multimorbidity guidelines have been produced
Minimally Disruptive Medicine: Is healthcare careful? Is it kind?
MedEdPurls has three posts on Teaching Multimorbidity:
http://mededpurls.com/blog/index.php/2016/10/31/teaching-multimorbidity-part-one/
http://mededpurls.com/blog/index.php/2016/11/05/teaching-multimorbidity-part-two/
http://mededpurls.com/blog/index.php/2016/11/13/teaching-multimorbidity-part-three/
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreOver 3% of GP consultations in Australia involve skin lesions, yet many practices are billing these procedures incorrectly, putting themselves at risk of noncompliance or missing out on legitimate remuneration. This Business skills FastTrack explains the MBS item numbers pertaining to skin lesions for GPs, including eligibility criteria and practical tips.
Sarcoidosis is a chronic non-caseating granulomatous condition affecting multiple organ systems. This fact sheet contains what GPs need to know about risk factors, investigations, pharmacological and non-pharmacological management in primary practice, and when to refer. 30mins each of RP and EA CPD available with the quiz.
Discover practical strategies for GPs to identify and manage anxiety and depression in adolescents, balancing non-pharmacological care with thoughtful, evidence-based prescribing when needed. Find out how the Quality Use of Medicines Alliance is helping health professionals navigate this complex area with new clinical tools, national education programs and expert-led insights.